http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0015038-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-86
filingDate 1980-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1984-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1984-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0015038-B1
titleOfInvention Pharmaceutical composition containing a diphenylhydantoin derivative, derivatives used and their preparation
abstract Psychotropic composition comprising as an active constituent, a pharmaceutical composition, more particularly a psychotropic composition, characterized in that it comprises as an active constituent, a deuterated phenylhydantoin corresponding to the general formula <IMAGE> wherein radicals R1 are identical or different and represent hydrogen or methyl, R2 is ethyl or a substituted or unsubstituted phenyl group, which is deuterated or not, R3 is hydrogen, halogen or a linear or ramified alkyl radical comprising 1 to 4 carbon atoms, a linear or ramified alkoxy radical comprising 1 to 4 carbon atoms, a trifluoromethyl, hydroxy, nitro or amino radical, X is an oxo, thio or methylene group and x is an integer of 1-5, one of its enantioners or one of its salts with a physiologically acceptable base, in combination with a pharmaceutically acceptable vehicle.
priorityDate 1979-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID233040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID570576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13019272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226724918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236323300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6913196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236316696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6913198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226516535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227177506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235803073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12210018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88722806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227553172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235805340
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227032831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226450030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236319339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID619818

Total number of triples: 41.